《半日總結》恆指半日升213點 復星醫藥升逾4% 創維急飆兩成
輝瑞藥廠指「復必泰」有效應對新冠變種Omicron,道指升35點或0.1%,港股早市在科技股帶動下造好。恆指高開171點,其後升幅曾擴大至327點見24,324點,半日升213點或0.89%,報24,210點;國指升119點或1.4%,報8,642點;恆生科技指數升122點或2.05%,報6,092點。大市半日成交總額708.56億元,滬、深港通南下交易半日分別淨流入5.4億及11.46億元人民幣。
科技股方面,阿裏巴巴(09988.HK)成立子公司加碼佈局元宇宙,股價升1.8%報122.8元。騰訊(00700.HK)升1.2%報472.4元,美團(03690.HK)外賣應用程式出故障,股價升幅收窄至1.1%報247.8元。據報小米(01810.HK)斥15億人幣在滬成立集成電路芯片設計公司,小米升0.6%報19.34元。京東(09618.HK)升1.4%報311.4元。網易(09999.HK)則跌0.2%。
據報快手(01024.HK)準備裁員最多30%,快手低開後倒升3%報86.7元。萬國數據(09698.HK)夥深圳燃氣及三環集團達成清潔能源技術戰略合作,股價抽升7.1%。網絡醫健股阿裏健康(00241.HK)及京東健康(06618.HK)各升逾5%,網絡保險股衆安在線(06060.HK)亦升5.5%。手機相關股方面,瑞聲(02018.HK)遭摩通下調目標價,股價仍升1.8%。舜宇(02382.HK)升2.9%。
輝瑞指「復必泰」有效應對新冠變種Omicron,復星醫藥(02196.HK)升4.1%,生物科技股信達生物(01801.HK)及中生製藥(01177.HK)各升3.6%及3.8%。石藥(01093.HK)炒高5.4%。
發改委提出實施傢俱家裝下鄉補貼和新一輪汽車下鄉,創維(00751.HK)急升20.4%報5.96元,海爾智家(06690.HK)升3.7%。汽車股吉利(00175.HK)、廣汽(02238.HK)及長汽(02333.HK)各升1.8%至1.9%。其餘內需股見支持,海底撈(06862.HK)升2.6%,蒙牛(02319.HK)、百威亞太(01876.HK)及潤啤(00291.HK)各升2.8%至3.4%。電子煙概念股方面,比亞迪電子(00285.HK)及思摩爾國際(06969.HK)各升4.4%及2.8%。華寶國際(00336.HK)折讓11.9%配股淨籌21.6億元上板,股價跌6.6%報18.96元。
據報銀娛及澳博維持營運中介人貴賓廳,金沙續自營貴賓廳,濠賭股銀娛(00027.HK)及澳博(00880.HK)各跌0.5%及0.4%,金沙中國(01928.HK)則升3.3%。內房股見反彈,龍湖(00960.HK)及融創(01918.HK)各升2.9%及2.5%。恆大(03333.HK)及恆大物業(06666.HK)各升3.5%及3.2%。內地物管股碧桂園服務(06098.HK)升4.3%。
其他藍籌股方面,匯控(00005.HK)跌0.4%報45.3元,港交所(00388.HK)升0.1%報471.8元,友邦(01299.HK)跌0.2%報83元。招行(03968.HK)及國壽(02628.HK)各升逾2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.